| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
1.86 0 (0%) |
01-18 16:00 |
|
Open: |
1.9 |
Pre close: |
1.86 |
Target:
|
2.45 
|
|
High: |
1.9198 |
Low: |
1.85 |
Resistance:
|
2.10
2.51
|
|
Volume: |
43,127 |
Market Cap: |
14M |
Support:
|
1.44
1.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.88
|
MACD |
MACD(12,26):
|
-0.18  |
|
MA(20): |
1.86 |
Signal(12,26,9): |
-0.24 |
|
MA(100): |
3.03 |
Stochastic Oscillator |
%K(14,3):
|
45.05 |
|
MA(250): |
2.76 |
%D(3): |
47.01 |
|
Average Volume(K) |
3-Month: |
40167
|
52-Week |
High:
|
5.75 |
|
10-Days: |
13650 |
Low: |
1.44 |
|
RSI |
RSI(14):
|
40.94 |
Change(%): |
-34.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-289.9 |
Shares Out. (M) |
7.42 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-221.7 |
Shares Float (M) |
7.28 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.70 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.70 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
15.100 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.12 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.18 |
P/S |
0.00 |
|
Operating Margin |
-69296.92 |
Levered Free Cash Flow
(M) |
-3.24 |
P/CF |
-1.92 |
|
|
|
|
|
|
